Richmond's Phlow closes $36M Series B round
April 19, 2023 at 14:33 PM EDT
The public benefit corporation seeks to manufacture high-quality, essential generic drugs at a low cost.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|